| Dec 31,
2022 | Dec 31,
2023 | Dec 31,
2024 |
|---|
| Net income (loss) | -7,605,542 | -4,911,374 | -6,992,927 |
|---|
| Depreciation and amortization | - | - | 193,139 |
|---|
| Share-based compensation | 1 | 456,001 | 287,455 |
|---|
| Amortization of deferred issuance costs | - | 497,656 | 471,387 |
|---|
| Changes in fair value of warrants and derivative | - | -646,319 | -335,033 |
|---|
| Non-cash interest related to bridge funding | - | 98,685 | 58,002 |
|---|
| Gain (Loss) on exchange of debt | - | - | 1 |
|---|
| Loss on extinguishment of debt | - | - | -111,928 |
|---|
| Non-cash expenses related to equity line agreement | - | - | 425,367 |
|---|
| Accounts receivable | 12,290 | 1,491 | -7,271 |
|---|
| Prepaids and other current assets | 267,383 | 38,539 | 287,663 |
|---|
| Accounts payable | -603,102 | 220,633 | -156,403 |
|---|
| Accrued and other liabilities | 1 | 448,459 | -127,449 |
|---|
| Accrued interest on promissory and convertible notes | 200,712 | -6,190 | - |
|---|
| Net cash (used in) operations | -5,314,171 | -3,646,947 | -5,271,609 |
|---|
| Fixed assets | - | - | 5,115 |
|---|
| Intangible assets - Patents | 208,870 | 119,522 | 316,822 |
|---|
| Net cash (used in) investing activities | -207,870 | -119,522 | -321,937 |
|---|
| Bridge funding cash issuance costs | - | 323,301 | - |
|---|
| Equity line cash issuance costs | - | - | 367,865 |
|---|
| Preferred stock cash issuance costs | - | - | 90,000 |
|---|
| Common stock cash issuance costs | - | - | 788,099 |
|---|
| Proceeds from equity line | - | 1 | 2 |
|---|
| Proceeds from issuance of promissory notes | - | 2 | - |
|---|
| Proceeds from sale of preferred stock | - | 1,000 | 1,000,000 |
|---|
| Redemption of preferred stock | - | 1,000 | - |
|---|
| Proceeds from sale of common stock and warrants, Reg A+ | - | - | 529,254 |
|---|
| Proceeds from sale of common stock and warrants, ATM | - | - | 288,294 |
|---|
| Repayment of promissory notes | 2 | - | 300,973 |
|---|
| Proceeds from sale of common stock and warrants related to public offering | - | - | 3 |
|---|
| Net cash provided by financing activities | 7 | 3 | 5 |
|---|
| Net increase (decrease) in cash and cash equivalents | 1 | -451,737 | -567,408 |
|---|
| Cash paid for interest | - | - | 13,072 |
|---|
| Issuance of warrants related to bridge funding | - | 67,500 | - |
|---|
| Original issuance discount (15%) related to bridge funding | - | 344,118 | - |
|---|
| Liability to issue common shares | 345,243 | 33,297 | - |
|---|
| Issuance of commitment shares related to bridge funding | - | 175,619 | - |
|---|
| Fair value of warrants and derivative related to first tranche bridge funding | - | 742,988 | - |
|---|
| Fair value of warrants and derivative related to second tranche bridge funding | - | 153,810 | - |
|---|
| Fair value of warrants and derivative related to third tranche bridge funding | - | 160,012 | - |
|---|
| Dividends accrued on preferred shares | 415,523 | - | 59,675 |
|---|
| Exchange of indebtedness for common shares | - | - | 2 |
|---|
| Exchange of indebtedness for preferred shares | - | - | 930,052 |
|---|
| Conversion of preferred stock to common stock | 26 | - | 129,999 |
|---|
| Issuance of common shares related to restricted stock units | - | - | 216,597 |
|---|
| Issuance of commitment shares related to bridge funding | - | - | 33,297 |
|---|